Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 7.871
Filtrar
3.
Emerg Infect Dis ; 30(6): 1249-1252, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38782141

RESUMEN

Burkholderia semiarida was previously identified solely as a plant pathogen within the Burkholderia cepacia complex. We present a case in China involving recurrent pneumonia attributed to B. semiarida infection. Of note, the infection manifested in an immunocompetent patient with no associated primary diseases and endured for >3 years.


Asunto(s)
Infecciones por Burkholderia , Burkholderia , Recurrencia , Humanos , Infecciones por Burkholderia/diagnóstico , Infecciones por Burkholderia/microbiología , Infecciones por Burkholderia/tratamiento farmacológico , China , Burkholderia/aislamiento & purificación , Burkholderia/genética , Masculino , Inmunocompetencia , Antibacterianos/uso terapéutico , Persona de Mediana Edad , Neumonía Bacteriana/microbiología , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/tratamiento farmacológico
4.
Emerg Infect Dis ; 30(6): 1263-1266, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38782145

RESUMEN

We retrospectively analyzed of 211 frozen cerebrospinal fluid samples from immunocompetent persons in the Czech Republic and detected 6 Encephalitozoon cuniculi-positive samples. Microsporidiosis is generally underestimated and patients are not usually tested for microsporidia, but latent infection in immunodeficient and immunocompetent patients can cause serious complications if not detected and treated.


Asunto(s)
Encephalitozoon cuniculi , Encefalitozoonosis , Humanos , República Checa/epidemiología , Encephalitozoon cuniculi/aislamiento & purificación , Encephalitozoon cuniculi/genética , Encefalitozoonosis/líquido cefalorraquídeo , Encefalitozoonosis/microbiología , Encefalitozoonosis/epidemiología , Masculino , Femenino , Persona de Mediana Edad , Adulto , Estudios Retrospectivos , Anciano , Inmunocompetencia
5.
J Immunother Cancer ; 12(5)2024 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-38702144

RESUMEN

BACKGROUND: Natural killer (NK) cells are key effector cells of antitumor immunity. However, tumors can acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying mechanisms that mediate this resistance enables us to define approaches to improve immune-mediate antitumor activity. In previous studies from our group, a genome-wide CRISPR-Cas9 screen identified Charged Multivesicular Body Protein 2A (CHMP2A) as a novel mechanism that mediates tumor intrinsic resistance to NK cell activity. METHODS: Here, we use an immunocompetent mouse model to demonstrate that CHMP2A serves as a targetable regulator of not only NK cell-mediated immunity but also other immune cell populations. Using the recently characterized murine 4MOSC model system, a syngeneic, tobacco-signature murine head and neck squamous cell carcinoma model, we deleted mCHMP2A using CRISPR/Cas9-mediated knock-out (KO), following orthotopic transplantation into immunocompetent hosts. RESULTS: We found that mCHMP2A KO in 4MOSC1 cells leads to more potent NK-mediated tumor cell killing in vitro in these tumor cells. Moreover, following orthotopic transplantation, KO of mCHMP2A in 4MOSC1 cells, but not the more immune-resistant 4MOSC2 cells enables both T cells and NK cells to better mediate antitumor activity compared with wild type (WT) tumors. However, there was no difference in tumor development between WT and mCHMP2A KO 4MOSC1 or 4MOSC2 tumors when implanted in immunodeficient mice. Mechanistically, we find that mCHMP2A KO 4MOSC1 tumors transplanted into the immunocompetent mice had significantly increased CD4+T cells, CD8+T cells. NK cell, as well as fewer myeloid-derived suppressor cells (MDSC). CONCLUSIONS: Together, these studies demonstrate that CHMP2A is a targetable inhibitor of cellular antitumor immunity.


Asunto(s)
Modelos Animales de Enfermedad , Neoplasias de Cabeza y Cuello , Células Asesinas Naturales , Carcinoma de Células Escamosas de Cabeza y Cuello , Animales , Humanos , Ratones , Línea Celular Tumoral , Neoplasias de Cabeza y Cuello/inmunología , Neoplasias de Cabeza y Cuello/genética , Inmunocompetencia , Células Asesinas Naturales/inmunología , Carcinoma de Células Escamosas de Cabeza y Cuello/inmunología , Carcinoma de Células Escamosas de Cabeza y Cuello/genética
6.
Am J Case Rep ; 25: e942660, 2024 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-38702880

RESUMEN

BACKGROUND Histoplasmosis is typically associated with immunocompromised individuals, but cases in immunocompetent patients are rare. Primary cutaneous histoplasmosis (PCH) is a challenging diagnosis due to its clinical polymorphism and can mimic other infectious and non-infectious diseases. Previous cases of PCH have been reported in immunocompetent patients with underlying medical conditions or trauma history. So far there have been no reports of PCH after platelet-rich plasma (PRP) application due to inadequate hygiene measures in an immunocompetent host. CASE REPORT This case report presents a rare occurrence of PCH following a cosmetic procedure (PRP injection) in an immunocompetent patient. The patient developed nodule-like lesions at the application sites, which progressed to ulceration with purulent discharge. Initially, atypical mycobacterial infection was suspected, and empirical antibiotic therapy was initiated. Complementary tests were performed, ruling out immunosuppression and systemic pathogens. The patient showed complete resolution of the lesions after one month of atypical treatment with trimethoprim-sulfamethoxazole (TMP/SMX). Pathological examination confirmed the diagnosis of PCH with intracytoplasmic inclusions of Histoplasma sp. CONCLUSIONS This case highlights the importance of considering histoplasmosis as a diagnostic possibility, especially in hyperendemic areas like Venezuela. Direct inoculation of Histoplasma sp. after aesthetic procedures without proper hygiene measures can lead to pathological lesions, even in immunocompetent individuals. TMP/SMX can be considered as an alternative treatment option in the absence of the first-line medication. Further exploration of this treatment approach may benefit patients with similar clinical conditions or when ideal treatment options are unavailable.


Asunto(s)
Histoplasmosis , Plasma Rico en Plaquetas , Combinación Trimetoprim y Sulfametoxazol , Humanos , Histoplasmosis/diagnóstico , Histoplasmosis/tratamiento farmacológico , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico , Femenino , Técnicas Cosméticas/efectos adversos , Dermatomicosis/tratamiento farmacológico , Dermatomicosis/diagnóstico , Inmunocompetencia , Adulto
9.
Artículo en Inglés | MEDLINE | ID: mdl-38656040

RESUMEN

Inactivated COVID-19 vaccines data in immunocompromised individuals are scarce. This trial assessed the immunogenicity of two CoronaVac doses and additional BNT162b2 mRNA vaccine doses in immunocompromised (IC) and immunocompetent (H) individuals. Adults with solid organ transplant (SOT), hematopoietic stem cell transplant, cancer, inborn immunity errors or rheumatic diseases were included in the IC group. Immunocompetent adults were used as control group for comparison. Participants received two CoronaVac doses within a 28-day interval. IC received two additional BNT162b2 doses and H received a third BNT162b2 dose (booster). Blood samples were collected at baseline, 28 days after each dose, pre-booster and at the trial end. We used three serological tests to detect antibodies to SARS-CoV-2 nucleocapsid (N), trimeric spike (S), and receptor binding domain (RBD). Outcomes included seroconversion rates (SCR), geometric mean titers (GMT) and GMT ratio (GMTR). A total of 241 IC and 100 H adults participated in the study. After two CoronaVac doses, IC had lower SCR than H: anti-N, 33.3% vs 79%; anti-S, 33.8% vs 86%, and anti-RBD, 48.5% vs 85%, respectively. IC also showed lower GMT than H: anti-N, 2.3 vs 15.1; anti-S, 58.8 vs 213.2 BAU/mL; and anti-RBD, 22.4 vs 168.0 U/mL, respectively. After the 3rd and 4th BNT162b2 doses, IC had significant anti-S and anti-RBD seroconversion, but still lower than H after the 3rd dose. After boosting, GMT increased in IC, but remained lower than in the H group. CoronaVac two-dose schedule immunogenicity was lower in IC than in H. BNT162b2 heterologous booster enhanced immune response in both groups.


Asunto(s)
Anticuerpos Antivirales , Vacuna BNT162 , Vacunas contra la COVID-19 , COVID-19 , Huésped Inmunocomprometido , Inmunogenicidad Vacunal , SARS-CoV-2 , Humanos , Huésped Inmunocomprometido/inmunología , Vacuna BNT162/inmunología , Vacuna BNT162/administración & dosificación , Masculino , Femenino , Adulto , Persona de Mediana Edad , COVID-19/prevención & control , COVID-19/inmunología , Vacunas contra la COVID-19/inmunología , Vacunas contra la COVID-19/administración & dosificación , Anticuerpos Antivirales/sangre , SARS-CoV-2/inmunología , Vacunas de Productos Inactivados/inmunología , Vacunas de Productos Inactivados/administración & dosificación , Anciano , Inmunocompetencia/inmunología , Adulto Joven , Inmunización Secundaria
10.
Parasit Vectors ; 17(1): 164, 2024 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-38555448

RESUMEN

BACKGROUND: The immunocompetence handicap hypothesis suggests that males with a higher testosterone level should be better at developing male secondary traits, but at a cost of suppressed immune performance. As a result, we should expect that males with an increased testosterone level also possess a higher parasite load. However, previous empirical studies aimed to test this prediction have generated mixed results. Meanwhile, the effect of testosterone level on parasite load in female hosts remains poorly known. METHODS: In this study, we tested this prediction by manipulating testosterone level in Daurian ground squirrels (Spermophilus dauricus), a medium-sized rodent widely distributed in northeast Asia. S. dauricus is an important host of ticks and fleas and often viewed as a considerable reservoir of plague. Live-trapped S. dauricus were injected with either tea oil (control group) or testosterone (treatment group) and then released. A total of 10 days later, the rodents were recaptured and checked for ectoparasites. Fecal samples were also collected to measure testosterone level of each individual. RESULTS: We found that testosterone manipulation and sex of hosts interacted to affect tick load. At the end of the experiment, male squirrels subjected to testosterone implantation had an averagely higher tick load than males from the control group. However, this pattern was not found in females. Moreover, testosterone manipulation did not significantly affect flea load in S. dauricus. CONCLUSIONS: Our results only lent limited support for the immunocompetence handicap hypothesis, suggesting that the role of testosterone on regulating parasite load is relatively complex, and may largely depend on parasite type and gender of hosts.


Asunto(s)
Infestaciones por Pulgas , Enfermedades de los Roedores , Siphonaptera , Garrapatas , Animales , Femenino , Masculino , Sciuridae/parasitología , Infestaciones por Pulgas/veterinaria , Testosterona/fisiología , Inmunocompetencia/fisiología
11.
JAMA Dermatol ; 160(5): 567-568, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38446440

RESUMEN

A male patient was evaluated by the dermatology inpatient consult service after a 5-week history of a skin lesion on the right anterior thigh with intermittent itching and mild tenderness to palpation. What is your diagnosis?


Asunto(s)
Inmunocompetencia , Humanos , Masculino , Eritema/diagnóstico , Eritema/patología , Biopsia , Femenino , Persona de Mediana Edad
12.
Virol J ; 21(1): 39, 2024 02 09.
Artículo en Inglés | MEDLINE | ID: mdl-38336670

RESUMEN

Pneumonia is the most common complication of varicella infections. Although previous studies have tended to focus mainly on immunocompromised patients, varicella pneumonia can also occur in healthy adults. Therefore, in this study, we aimed to assess the progression of varicella pneumonia in immunocompetent hosts. This retrospective study involved immunocompetent adult outpatients with varicella who attended the adult Fever Emergency facility of Peking University Third Hospital from April 1, 2020, to October 31, 2022. Varicella pneumonia was defined as a classic chickenpox-type rash in patients with infiltrates on chest computed tomography. The study included 186 patients, 57 of whom had a contact history of chickenpox exposure. Antiviral pneumonia therapy was administered to 175 patients by treating physicians. Computed tomography identified pneumonia in 132 patients, although no deaths from respiratory failure occurred. Seventy of the discharged patients were subsequently contacted, all of whom reported being well. Follow-up information, including computed tomography findings, was available for 37 patients with pneumonia, among whom 24 reported complete resolution whereas the remaining 13 developed persistent calcifications. Notably, we established that the true incidence of varicella pneumonia is higher than that previously reported, although the prognosis for immunocompetent hosts is generally good.


Asunto(s)
Varicela , Neumonía Viral , Adulto , Humanos , Varicela/complicaciones , Varicela/epidemiología , Estudios Retrospectivos , Prevalencia , Neumonía Viral/complicaciones , Neumonía Viral/epidemiología , Inmunocompetencia , Herpesvirus Humano 3
13.
J Cutan Pathol ; 51(6): 403-406, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38419370

RESUMEN

Cutaneous pseudolymphomas are a wide group of diseases mimicking cutaneous lymphoma. They comprise several skin conditions with different etiopathogenesis, clinical-pathological features, and prognosis, which may occur in the absence of an identifiable trigger factor or after administration of medications or vaccinations, tattoos, infections, or arthropod bites. They present with different manifestations: from solitary to regionally clustered lesions, up to generalized distribution and, in rare cases, erythroderma. They persist variably, from weeks to years, and resolve spontaneously or after antibiotics, but may recur in some cases. CD30+ T-cell pseudolymphomas are characterized by the presence of large, activated lymphoid cells, generally in response to viral infections, arthropod assault reactions, and drug eruptions. Stenotrophomonas maltophilia is a ubiquitous Gram-negative bacillus responsible for opportunistic infections in immunocompromised patients. Infection of intact skin in immunocompetent patients is particularly rare. Here, we report a case of a man presenting an isolated nodule histopathologically mimicking a primary cutaneous CD30+ T-cell lymphoproliferative disorder.


Asunto(s)
Trastornos Linfoproliferativos , Seudolinfoma , Stenotrophomonas maltophilia , Humanos , Stenotrophomonas maltophilia/aislamiento & purificación , Masculino , Trastornos Linfoproliferativos/patología , Trastornos Linfoproliferativos/microbiología , Trastornos Linfoproliferativos/diagnóstico , Seudolinfoma/patología , Seudolinfoma/diagnóstico , Seudolinfoma/microbiología , Seudolinfoma/inmunología , Antígeno Ki-1/metabolismo , Infecciones por Bacterias Gramnegativas/diagnóstico , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Gramnegativas/patología , Diagnóstico Diferencial , Linfocitos T/inmunología , Linfocitos T/patología , Enfermedades Cutáneas Bacterianas/patología , Enfermedades Cutáneas Bacterianas/diagnóstico , Enfermedades Cutáneas Bacterianas/microbiología , Enfermedades Cutáneas Bacterianas/inmunología , Persona de Mediana Edad , Inmunocompetencia
17.
N Engl J Med ; 390(6): 522-529, 2024 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-38324485

RESUMEN

A multinational outbreak of nosocomial fusarium meningitis occurred among immunocompetent patients who had undergone surgery with epidural anesthesia in Mexico. The pathogen involved had a high predilection for the brain stem and vertebrobasilar arterial system and was associated with high mortality from vessel injury. Effective treatment options remain limited; in vitro susceptibility testing of the organism suggested that it is resistant to all currently approved antifungal medications in the United States. To highlight the severe complications associated with fusarium infection acquired in this manner, we report data, clinical courses, and outcomes from 13 patients in the outbreak who presented with symptoms after a median delay of 39 days.


Asunto(s)
Brotes de Enfermedades , Fusariosis , Fusarium , Enfermedad Iatrogénica , Meningitis Fúngica , Humanos , Antifúngicos/uso terapéutico , Fusariosis/epidemiología , Fusariosis/etiología , Fusarium/aislamiento & purificación , Enfermedad Iatrogénica/epidemiología , Meningitis Fúngica/epidemiología , Meningitis Fúngica/etiología , México/epidemiología , Brotes de Enfermedades/estadística & datos numéricos , Internacionalidad , Inmunocompetencia , Farmacorresistencia Fúngica , Analgesia Epidural/efectos adversos
19.
Mult Scler ; 30(6): 755-758, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38247156

RESUMEN

BACKGROUND: Fungal infections of the central nervous system usually affect immunocompromised patients. Primary Aspergillus myelitis has never been described. REPORT: A 45-year-old immunocompetent male with subacute paraplegia was treated for inflammatory myelitis before clinical deterioration requiring mechanical ventilation. Purulent meningitis preceded the formation of a paraspinal nodule biopsied by neurosurgery. Histopathological analysis revealed the presence of fungal hyphae, and polymerase chain reaction was positive for Aspergillus fumigatus. No cause of immunodeficiency was identified in this patient. DISCUSSION: Primary Aspergillus myelitis may be confused with inflammatory myelitis and should be considered even in the absence of apparent immunosuppression.


Asunto(s)
Mielitis , Humanos , Masculino , Persona de Mediana Edad , Mielitis/microbiología , Aspergillus fumigatus/aislamiento & purificación , Inmunocompetencia , Imagen por Resonancia Magnética , Neuroaspergilosis , Aspergilosis/complicaciones , Aspergilosis/diagnóstico , Antifúngicos/uso terapéutico
20.
Value Health Reg Issues ; 41: 54-62, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38241885

RESUMEN

OBJECTIVES: To determine the cost-effectiveness of the QuantiFERON-TB Gold Plus (QFT-Plus) test versus the tuberculin skin test in diagnosing latent tuberculosis infection in immunocompetent subjects in the context of the Colombian healthcare system. METHODS: A hypothetical cohort of 2000 immunocompetent adults vaccinated with Bacillus Calmette-Guérin at birth who are asymptomatic for tuberculosis disease was simulated and included in a decision tree over a horizon of <1 year. The direct healthcare costs related to tests, antituberculosis treatment, and medical care were considered, and diagnostic performance was used as a measure of effectiveness. The incremental cost-effectiveness ratio (ICER) was estimated, and univariate deterministic and probabilistic sensitivity analyses were carried out using 5000 simulations. The currency was the US dollar for the year 2022, with a cost-effectiveness threshold of $6666 USD (1 gross domestic product per capita for 2022). RESULTS: QFT-Plus was cost-effective with an ICER of $5687 USD for each correctly diagnosed case relative to a threshold of $6666 USD. In the deterministic analysis, QFT-Plus was cost-effective in half of the proposed scenarios. The variable that most affected the ICER was the prevalence of latent tuberculosis and test sensitivities. In the probabilistic analysis, QFT-Plus was cost-effective in 54.74% of the simulated scenarios, and tuberculin skin test was dominant in 13.84%. CONCLUSIONS: The study provides evidence of the cost-effectiveness of QFT-Plus compared with the tuberculin skin test in diagnosing latent tuberculosis infection in immunocompetent adults in the Colombian context.


Asunto(s)
Análisis Costo-Beneficio , Tuberculosis Latente , Prueba de Tuberculina , Humanos , Análisis Costo-Beneficio/métodos , Prueba de Tuberculina/métodos , Prueba de Tuberculina/economía , Colombia/epidemiología , Tuberculosis Latente/diagnóstico , Tuberculosis Latente/economía , Tuberculosis Latente/epidemiología , Adulto , Sensibilidad y Especificidad , Ensayos de Liberación de Interferón gamma/economía , Ensayos de Liberación de Interferón gamma/métodos , Ensayos de Liberación de Interferón gamma/normas , Inmunocompetencia , Análisis de Costo-Efectividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA